-
1
-
-
65249171425
-
Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects
-
Møller, N. & Jørgensen, J. O. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152-177 (2009).
-
(2009)
Endocr. Rev.
, vol.30
, pp. 152-177
-
-
Møller, N.1
Jørgensen, J.O.2
-
2
-
-
0002751873
-
Effects of human growth hormone on muscle and adipose tissue metabolism in the forearm of man
-
Rabinowitz, D., Klassen, G. A. & Zierler, K. L. Effects of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J. Clin. Invest. 44, 51-61 (1965).
-
(1965)
J. Clin. Invest.
, vol.44
, pp. 51-61
-
-
Rabinowitz, D.1
Klassen, G.A.2
Zierler, K.L.3
-
3
-
-
0014440037
-
Calorigenic effect of human growth hormone in obesity
-
Bray, G. A. Calorigenic effect of human growth hormone in obesity. J. Clin. Endocrinol. Metab. 29, 119-122 (1969).
-
(1969)
J. Clin. Endocrinol. Metab.
, vol.29
, pp. 119-122
-
-
Bray, G.A.1
-
4
-
-
0027514167
-
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
-
Bengtsson, B. A. et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. 76, 309-317 (1993).
-
(1993)
J. Clin. Endocrinol. Metab.
, vol.76
, pp. 309-317
-
-
Bengtsson, B.A.1
-
5
-
-
0028264279
-
Growth hormone and hepatic lipoprotein metabolism
-
Angelin, B. & Rudling, M. Growth hormone and hepatic lipoprotein metabolism. Curr. Opin. Lipidol. 5, 160-165 (1994).
-
(1994)
Curr. Opin. Lipidol.
, vol.5
, pp. 160-165
-
-
Angelin, B.1
Rudling, M.2
-
6
-
-
0027970820
-
Growth hormone and the heart
-
Saccà, L., Cittadini, A. & Fazio, S. Growth hormone and the heart. Endocr. Rev. 15, 555-573 (1994).
-
(1994)
Endocr. Rev.
, vol.15
, pp. 555-573
-
-
Saccà, L.1
Cittadini, A.2
Fazio, S.3
-
7
-
-
0030454148
-
Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency
-
Böger, R. H. et al. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J. Clin. Invest. 98, 2706-2713 (1996).
-
(1996)
J. Clin. Invest.
, vol.98
, pp. 2706-2713
-
-
Böger, R.H.1
-
8
-
-
0031792510
-
Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency
-
[No authors listed]
-
[No authors listed] Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J. Clin. Endocrinol. Metab. 83, 379-381 (1998).
-
(1998)
J. Clin. Endocrinol. Metab
, vol.83
, pp. 379-381
-
-
-
9
-
-
33847249410
-
Management of adult growth hormone deficiency
-
Johannsson, G. Management of adult growth hormone deficiency. Endocrinol. Metab. Clin. North Am. 36, 203-220 (2007).
-
(2007)
Endocrinol. Metab. Clin. North Am.
, vol.36
, pp. 203-220
-
-
Johannsson, G.1
-
10
-
-
2442526224
-
Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: A meta-analysis of blinded, randomized, placebo-controlled trials
-
Maison, P. et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a meta-analysis of blinded, randomized, placebo-controlled trials. J. Clin. Endocrinol. Metab. 89, 2192-2199 (2004).
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 2192-2199
-
-
Maison, P.1
-
11
-
-
0034887335
-
Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors
-
Clasey, J. L. et al. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J. Clin. Endocrinol. Metab. 86, 3845-3852 (2001).
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 3845-3852
-
-
Clasey, J.L.1
-
12
-
-
0030737928
-
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults
-
Vahl, N. et al. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am. J. Physiol. 272, E1108-E1116 (1997).
-
(1997)
Am. J. Physiol.
, vol.272
-
-
Vahl, N.1
-
13
-
-
0030663542
-
Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: Relation to age, sex, and body composition
-
Vahl, N., Møller, N., Lauritzen, T., Christiansen, J. S. & Jørgensen, J. O. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. J. Clin. Endocrinol. Metab. 82, 3612-3618 (1997).
-
(1997)
J. Clin. Endocrinol. Metab.
, vol.82
, pp. 3612-3618
-
-
Vahl, N.1
Møller, N.2
Lauritzen, T.3
Christiansen, J.S.4
Jørgensen, J.O.5
-
14
-
-
77953171777
-
A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation
-
Lu, C., Kumar, P. A., Fan, Y., Sperling, M. A. & Menon, R. K. A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation. Endocrinology 151, 2189-2199 (2010).
-
(2010)
Endocrinology
, vol.151
, pp. 2189-2199
-
-
Lu, C.1
Kumar, P.A.2
Fan, Y.3
Sperling, M.A.4
Menon, R.K.5
-
15
-
-
33747079946
-
Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor i
-
Fleenor, D., Arumugam, R. & Freemark, M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm. Res. 66, 101-110 (2006).
-
(2006)
Horm. Res.
, vol.66
, pp. 101-110
-
-
Fleenor, D.1
Arumugam, R.2
Freemark, M.3
-
16
-
-
34547179806
-
Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells
-
Lyuh, E. et al. Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells. Growth Horm. IGF Res. 17, 315-322 (2007).
-
(2007)
Growth Horm. IGF Res.
, vol.17
, pp. 315-322
-
-
Lyuh, E.1
-
17
-
-
67349116804
-
Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system
-
Hattori, N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm. IGF Res. 19, 187-197 (2009).
-
(2009)
Growth Horm. IGF Res.
, vol.19
, pp. 187-197
-
-
Hattori, N.1
-
18
-
-
3242738413
-
Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: Relationship to GH-binding protein
-
Fisker, S. et al. Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein. Eur. J. Endocrinol. 150, 773-777 (2004).
-
(2004)
Eur. J. Endocrinol.
, vol.150
, pp. 773-777
-
-
Fisker, S.1
-
19
-
-
0035092767
-
Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: Impact of GH treatment
-
Fisker, S. et al. Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment. J. Clin. Endocrinol. Metab. 86, 792-796 (2001).
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 792-796
-
-
Fisker, S.1
-
20
-
-
0028154380
-
Growth hormone treatment of obese women for 5 wk: Effect on body composition and adipose tissue LPL activity
-
Richelsen, B. et al. Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am. J. Physiol. 266, E211-E216 (1994).
-
(1994)
Am. J. Physiol.
, vol.266
-
-
Richelsen, B.1
-
21
-
-
0034289895
-
The mechanism of effect of growth hormone on preadipocyte and adipocyte function
-
Nam, S. Y. & Lobie, P. E. The mechanism of effect of growth hormone on preadipocyte and adipocyte function. Obes Rev. 1, 73-86 (2000).
-
(2000)
Obes Rev.
, vol.1
, pp. 73-86
-
-
Nam, S.Y.1
Lobie, P.E.2
-
22
-
-
84861970804
-
The insulin-like growth factors in adipogenesis and obesity
-
v-vi
-
Garten, A., Schuster, S. & Kiess, W. The insulin-like growth factors in adipogenesis and obesity. Endocrinol. Metab. Clin. North Am. 41, 283-295, v-vi (2012).
-
(2012)
Endocrinol. Metab. Clin. North Am.
, vol.41
, pp. 283-295
-
-
Garten, A.1
Schuster, S.2
Kiess, W.3
-
23
-
-
77949525237
-
Aging, depot origin, and preadipocyte gene expression
-
Cartwright, M. J. et al. Aging, depot origin, and preadipocyte gene expression. J. Gerontol. A. Biol. Sci. Med. Sci. 65, 242-251 (2010).
-
(2010)
J. Gerontol. A. Biol. Sci. Med. Sci.
, vol.65
, pp. 242-251
-
-
Cartwright, M.J.1
-
24
-
-
33846032618
-
Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns
-
Tchkonia, T. et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am. J. Physiol. Endocrinol. Metab. 292, E298-E307 (2007).
-
(2007)
Am. J. Physiol. Endocrinol. Metab.
, vol.292
-
-
Tchkonia, T.1
-
25
-
-
84870273698
-
Clinical relevance of adipokines
-
Blüher, M. Clinical relevance of adipokines. Diabetes Metab. J. 36, 317-327 (2012).
-
(2012)
Diabetes Metab. J.
, vol.36
, pp. 317-327
-
-
Blüher, M.1
-
26
-
-
78650835266
-
The somatotrope as a metabolic sensor: Deletion of leptin receptors causes obesity
-
Childs, G. V. et al. The somatotrope as a metabolic sensor: deletion of leptin receptors causes obesity. Endocrinology 152, 69-81 (2011).
-
(2011)
Endocrinology
, vol.152
, pp. 69-81
-
-
Childs, G.V.1
-
27
-
-
84869233588
-
Human BAT possesses molecular signatures that resemble beige/brite cells
-
Sharp, L. Z. et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS ONE 7, e49452 (2012).
-
(2012)
PLoS ONE
, vol.7
-
-
Sharp, L.Z.1
-
28
-
-
81155138295
-
Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues
-
Lin, L. et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 10, 996-1010 (2011).
-
(2011)
Aging Cell
, vol.10
, pp. 996-1010
-
-
Lin, L.1
-
29
-
-
79955044996
-
Architecture and the extracellular matrix: The still unappreciated components of the adipose tissue
-
Divoux, A. & Clément, K. Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes. Rev. 12, e494-e503 (2011).
-
(2011)
Obes. Rev.
, vol.12
-
-
Divoux, A.1
Clément, K.2
-
30
-
-
0035168994
-
Gene expression in visceral and subcutaneous adipose tissues
-
Vidal, H. Gene expression in visceral and subcutaneous adipose tissues. Ann. Med. 33, 547-555 (2001).
-
(2001)
Ann. Med.
, vol.33
, pp. 547-555
-
-
Vidal, H.1
-
31
-
-
84872144478
-
Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complications
-
Lee, M. J., Wu, Y. & Fried, S. K. Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complications. Mol. Aspects Med. 34, 1-11 (2013).
-
(2013)
Mol. Aspects Med.
, vol.34
, pp. 1-11
-
-
Lee, M.J.1
Wu, Y.2
Fried, S.K.3
-
32
-
-
79957916782
-
Adipose tissue remodeling and obesity
-
Sun, K., Kusminski, C. M. & Scherer, P. E. Adipose tissue remodeling and obesity. J. Clin. Invest. 121, 2094-2101 (2011).
-
(2011)
J. Clin. Invest.
, vol.121
, pp. 2094-2101
-
-
Sun, K.1
Kusminski, C.M.2
Scherer, P.E.3
-
33
-
-
79958153897
-
Growth hormone and adipose tissue: Beyond the adipocyte
-
Berryman, D. E. et al. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm. IGF Res. 21, 113-123 (2011).
-
(2011)
Growth Horm. IGF Res.
, vol.21
, pp. 113-123
-
-
Berryman, D.E.1
-
34
-
-
84856467002
-
Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women
-
Erman, A., Veilleux, A., Tchernof, A. & Goodyer, C. G. Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women. Int. J. Obes. (Lond.) 35, 1511-1519 (2011).
-
(2011)
Int. J. Obes. (Lond.)
, vol.35
, pp. 1511-1519
-
-
Erman, A.1
Veilleux, A.2
Tchernof, A.3
-
35
-
-
0032239547
-
Pathophysiology of the neororegulation of growth hormone secretion in experimental animals and the human
-
Giustina, A. & Veldhuis, J. D. Pathophysiology of the neororegulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19, 717-797 (1998).
-
(1998)
Endocr. Rev.
, vol.19
, pp. 717-797
-
-
Giustina, A.1
Veldhuis, J.D.2
-
36
-
-
0025787687
-
Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men
-
Iranmanesh, A., Lizarralde, G. & Veldhuis, J. D. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73, 1081-1088 (1991).
-
(1991)
J. Clin. Endocrinol. Metab.
, vol.73
, pp. 1081-1088
-
-
Iranmanesh, A.1
Lizarralde, G.2
Veldhuis, J.D.3
-
37
-
-
0025973802
-
Dual effects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man
-
Veldhuis, J. D. et al. Dual effects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J. Clin. Endocrinol. Metab. 72, 51-59 (1991).
-
(1991)
J. Clin. Endocrinol. Metab.
, vol.72
, pp. 51-59
-
-
Veldhuis, J.D.1
-
38
-
-
0021746013
-
Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction
-
Williams, T. et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N. Engl. J. Med. 311, 1403-1407 (1984).
-
(1984)
N. Engl. J. Med.
, vol.311
, pp. 1403-1407
-
-
Williams, T.1
-
39
-
-
0029886765
-
Abdominal adiposity and physical fittness are major determinants of age associated decline in stimulated GH secretion in healthy adults
-
Vahl, N., Jørgensen, J. O., Jurik, A. G. & Christiansen, J. S. Abdominal adiposity and physical fittness are major determinants of age associated decline in stimulated GH secretion in healthy adults. J. Clin. Endocrinol. Metab. 81, 2209-2215 (1996).
-
(1996)
J. Clin. Endocrinol. Metab.
, vol.81
, pp. 2209-2215
-
-
Vahl, N.1
Jørgensen, J.O.2
Jurik, A.G.3
Christiansen, J.S.4
-
40
-
-
70349916249
-
Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity
-
Bredella, M. A. et al. Peak growth hormone-releasing hormone-arginine- stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J. Clin. Endocrinol. Metab. 94, 3995-4002 (2009).
-
(2009)
J. Clin. Endocrinol. Metab.
, vol.94
, pp. 3995-4002
-
-
Bredella, M.A.1
-
41
-
-
33747678664
-
Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity
-
Franco, C. et al. Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity. Eur. J. Endocrinol. 155, 261-268 (2006).
-
(2006)
Eur. J. Endocrinol.
, vol.155
, pp. 261-268
-
-
Franco, C.1
-
42
-
-
0032844435
-
Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults
-
Vahl, N., Klausen, I., Christiansen, J. S. & Jorgensen, J. O. Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults. Clin. Endocrinol. (Oxf.) 51, 309-316 (1999).
-
(1999)
Clin. Endocrinol. (Oxf.)
, vol.51
, pp. 309-316
-
-
Vahl, N.1
Klausen, I.2
Christiansen, J.S.3
Jorgensen, J.O.4
-
43
-
-
18144452003
-
Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults
-
Weltman, A. et al. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Metabolism 52, 73-80 (2003).
-
(2003)
Metabolism
, vol.52
, pp. 73-80
-
-
Weltman, A.1
-
44
-
-
14044276421
-
Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk
-
Miller, K. K. et al. Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J. Clin. Endocrinol. Metab. 90, 768-774 (2005).
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, pp. 768-774
-
-
Miller, K.K.1
-
45
-
-
47549103137
-
Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women
-
Utz, A. L., Yamamoto, A., Hemphill, L. & Miller, K. K. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J. Clin. Endocrinol. Metab. 93, 2507-2514 (2008).
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 2507-2514
-
-
Utz, A.L.1
Yamamoto, A.2
Hemphill, L.3
Miller, K.K.4
-
46
-
-
57349141683
-
The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men
-
Makimura, H., Stanley, T., Mun, D., You, S. M. & Grinspoon, S. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J. Clin. Endocrinol. Metab. 93, 4254-4260 (2008).
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 4254-4260
-
-
Makimura, H.1
Stanley, T.2
Mun, D.3
You, S.M.4
Grinspoon, S.5
-
47
-
-
0037369597
-
Blunted lipolytic response to fasting in abdominally obese women: Evidence for involvement of hyposomatotropism
-
Buijs, M. M. et al. Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism. Am. J. Clin. Nutr. 77, 544-550 (2003).
-
(2003)
Am. J. Clin. Nutr.
, vol.77
, pp. 544-550
-
-
Buijs, M.M.1
-
48
-
-
0035049818
-
Organization and evolution of the human growth hormone receptor gene 5'-flanking region
-
Goodyer, C. G. et al. Organization and evolution of the human growth hormone receptor gene 5'-flanking region. Endocrinology 142, 1923-1934 (2001).
-
(2001)
Endocrinology
, vol.142
, pp. 1923-1934
-
-
Goodyer, C.G.1
-
49
-
-
0346628520
-
Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism
-
Godowski, P. J. et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc. Natl Acad. Sci. USA 86, 8083-8087 (1989).
-
(1989)
Proc. Natl Acad. Sci. USA
, vol.86
, pp. 8083-8087
-
-
Godowski, P.J.1
-
50
-
-
3042780191
-
A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone
-
Dos Santos, C. et al. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat. Genet. 36, 720-724 (2004).
-
(2004)
Nat. Genet.
, vol.36
, pp. 720-724
-
-
Dos Santos, C.1
-
51
-
-
34548279858
-
GHR exon 3 polymorphism: Association with type 2 diabetes mellitus and metabolic disorder
-
Strawbridge, R. J. et al. GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder. Growth Horm. IGF Res. 17, 392-398 (2007).
-
(2007)
Growth Horm. IGF Res.
, vol.17
, pp. 392-398
-
-
Strawbridge, R.J.1
-
52
-
-
79957497637
-
The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children
-
Gao, L. et al. The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children. Pediatr. Diabetes 12, 429-434 (2011).
-
(2011)
Pediatr. Diabetes
, vol.12
, pp. 429-434
-
-
Gao, L.1
-
53
-
-
0015107186
-
Effects of triiodothyronine, growth hormone and anabolic steroids on nitrogen excretion and oxygen consumption of obese patients
-
Bray, G. A., Raben, M. S., Londono, J. & Gallagher, T. F. Jr. Effects of triiodothyronine, growth hormone and anabolic steroids on nitrogen excretion and oxygen consumption of obese patients. J. Clin. Endocrinol. Metab. 33, 293-300 (1971).
-
(1971)
J. Clin. Endocrinol. Metab.
, vol.33
, pp. 293-300
-
-
Bray, G.A.1
Raben, M.S.2
Londono, J.3
Gallagher Jr., T.F.4
-
54
-
-
0023251828
-
Growth hormone administration conserves lean body mass during dietary restriction in obese subjects
-
Clemmons, D. R., Snyder, D. K., Williams, R. & Underwood, L. E. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J. Clin. Endocrinol. Metab. 64, 878-883 (1987).
-
(1987)
J. Clin. Endocrinol. Metab.
, vol.64
, pp. 878-883
-
-
Clemmons, D.R.1
Snyder, D.K.2
Williams, R.3
Underwood, L.E.4
-
55
-
-
0023721904
-
Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: Effects on anabolism, lipolysis and body composition
-
Snyder, D. K., Clemmons, D. R. & Underwood, L. E. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis and body composition. J. Clin. Endocrinol. Metab. 67, 54-61 (1988).
-
(1988)
J. Clin. Endocrinol. Metab.
, vol.67
, pp. 54-61
-
-
Snyder, D.K.1
Clemmons, D.R.2
Underwood, L.E.3
-
56
-
-
0025146127
-
Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent
-
Snyder, D. K., Underwood, L. E. & Clemmons, D. R. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent. Am. J. Clin. Nutr. 52, 431-437 (1990).
-
(1990)
Am. J. Clin. Nutr.
, vol.52
, pp. 431-437
-
-
Snyder, D.K.1
Underwood, L.E.2
Clemmons, D.R.3
-
57
-
-
0033052163
-
Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults
-
Kim, K. R. et al. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults. Horm. Res. 51, 78-84 (1999).
-
(1999)
Horm. Res.
, vol.51
, pp. 78-84
-
-
Kim, K.R.1
-
58
-
-
0031825711
-
Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women
-
Tagliaferri, M. et al. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women. Int. J. Obes. Relat. Metab. Disord. 22, 836-841 (1998).
-
(1998)
Int. J. Obes. Relat. Metab. Disord.
, vol.22
, pp. 836-841
-
-
Tagliaferri, M.1
-
59
-
-
0027429860
-
Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency
-
Fowelin, J., Attvall, S., Lager, I. & Bengtsson, B. A. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42, 1443-1447 (1993).
-
(1993)
Metabolism
, vol.42
, pp. 1443-1447
-
-
Fowelin, J.1
Attvall, S.2
Lager, I.3
Bengtsson, B.A.4
-
60
-
-
0028233730
-
Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: A double-blind placebo-controlled study
-
Jørgensen, J. O. et al. Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: a double-blind placebo-controlled study. Metabolism 43, 872-877 (1994).
-
(1994)
Metabolism
, vol.43
, pp. 872-877
-
-
Jørgensen, J.O.1
-
61
-
-
0031970581
-
Effects of growth hormone treatment on the leptin system: Interactions with body composition and energy expenditure
-
Karlsson, C. et al. Effects of growth hormone treatment on the leptin system: interactions with body composition and energy expenditure. Eur. J. Endocrinol. 138, 408-414 (1998).
-
(1998)
Eur. J. Endocrinol.
, vol.138
, pp. 408-414
-
-
Karlsson, C.1
-
62
-
-
0024358129
-
Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomittant thyroxine-substituted central hypothyroidism
-
Jørgensen, J. O. et al. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomittant thyroxine-substituted central hypothyroidism. J. Clin. Endocrinol. Metab. 69, 1127-1132 (1989).
-
(1989)
J. Clin. Endocrinol. Metab.
, vol.69
, pp. 1127-1132
-
-
Jørgensen, J.O.1
-
63
-
-
0021678265
-
Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden
-
Lapidus, L. et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J. (Clin. Res. Ed.) 289, 1257-1261 (1984).
-
(1984)
Br. Med. J. (Clin. Res. Ed.)
, vol.289
, pp. 1257-1261
-
-
Lapidus, L.1
-
64
-
-
0021152686
-
Abdominal tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913
-
Larsson, B. et al. Abdominal tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913. Br. Med. J. (Clin. Res. Ed.) 288, 1401-1404 (1984).
-
(1984)
Br. Med. J. (Clin. Res. Ed.)
, vol.288
, pp. 1401-1404
-
-
Larsson, B.1
-
65
-
-
0031057076
-
Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
-
Johannsson, G. et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J. Clin. Endocrinol. Metab. 82, 727-734 (1997).
-
(1997)
J. Clin. Endocrinol. Metab.
, vol.82
, pp. 727-734
-
-
Johannsson, G.1
-
66
-
-
15944394754
-
Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: A 12-month placebo-controlled trial
-
Franco, C. et al. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J. Clin. Endocrinol. Metab. 90, 1466-1474 (2005).
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, pp. 1466-1474
-
-
Franco, C.1
-
67
-
-
34447126377
-
Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: A 12-month, randomized, placebo-controlled trial
-
Franco, C. et al. Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 92, 2644-2647 (2007).
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, pp. 2644-2647
-
-
Franco, C.1
-
68
-
-
48749093932
-
Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: A randomized controlled trial
-
Lo, J. et al. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial. JAMA 300, 509-519 (2008).
-
(2008)
JAMA
, vol.300
, pp. 509-519
-
-
Lo, J.1
-
69
-
-
0038813735
-
Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly
-
Clemmons, D. R. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 5, 181-183 (2002).
-
(2002)
Pituitary
, vol.5
, pp. 181-183
-
-
Clemmons, D.R.1
-
70
-
-
11144256210
-
Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion
-
Jessen, N. et al. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Am. J. Physiol. Endocrinol. Metab. 288, E194-E199 (2005).
-
(2005)
Am. J. Physiol. Endocrinol. Metab.
, vol.288
-
-
Jessen, N.1
-
71
-
-
47549084450
-
Growth hormone signaling in vivo in human muscle and adipose tissue: Impact of insulin, substrate background, and growth hormone receptor bckade
-
Nielsen, C. et al. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor bckade. J. Clin. Endocrinol. Metab. 93, 2842-2850 (2008).
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 2842-2850
-
-
Nielsen, C.1
-
72
-
-
1542466784
-
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice
-
Yakar, S. et al. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J. Clin. Invest. 113, 96-105 (2004).
-
(2004)
J. Clin. Invest.
, vol.113
, pp. 96-105
-
-
Yakar, S.1
-
73
-
-
27844460627
-
Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess
-
Barbour, L. A. et al. Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J. Biol. Chem. 280, 37489-37494 (2005).
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 37489-37494
-
-
Barbour, L.A.1
-
74
-
-
34249656368
-
Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue: Mechanism for growth hormone-mediated insulin resistance
-
del Rincon, J. P. et al. Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 56, 1638-1646 (2007).
-
(2007)
Diabetes
, vol.56
, pp. 1638-1646
-
-
Del Rincon, J.P.1
-
75
-
-
0038526307
-
Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle
-
Bramnert M. et al. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. J. Clin. Endocrinol. Metab. 88, 1455-1463 (2003).
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 1455-1463
-
-
Bramnert, M.1
-
76
-
-
0034901778
-
Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients
-
Nam, S. Y. et al. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 25, 1101-1107 (2001).
-
(2001)
Int. J. Obes. Relat. Metab. Disord.
, vol.25
, pp. 1101-1107
-
-
Nam, S.Y.1
-
77
-
-
33644929020
-
Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control
-
Ahn, C. W. et al. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control. Clin. Endocrinol. (Oxf.) 64, 444-449 (2006).
-
(2006)
Clin. Endocrinol. (Oxf.)
, vol.64
, pp. 444-449
-
-
Ahn, C.W.1
-
78
-
-
49749091133
-
Growth hormone and changes in energy balance in growth hormone deficient adults
-
Deepak, D. et al. Growth hormone and changes in energy balance in growth hormone deficient adults. Eur. J. Clin. Invest. 38, 622-627 (2008).
-
(2008)
Eur. J. Clin. Invest.
, vol.38
, pp. 622-627
-
-
Deepak, D.1
-
79
-
-
17944381371
-
Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency
-
Hernberg-Ståhl, E. et al. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J. Clin. Endocrinol. Metab. 86, 5277-5281 (2001).
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 5277-5281
-
-
Hernberg-Ståhl, E.1
-
80
-
-
0029057483
-
Energy and macronutrient intake in growth hormone-deficient adults: The effect of growth hormone replacement
-
Snel, Y. E., Brummer, R. J., Doerga, M. E., Zelissen, P. M. & Koppeschaar, H. P. Energy and macronutrient intake in growth hormone-deficient adults: the effect of growth hormone replacement. Eur. J. Clin. Nutr. 49, 492-500 (1995).
-
(1995)
Eur. J. Clin. Nutr.
, vol.49
, pp. 492-500
-
-
Snel, Y.E.1
Brummer, R.J.2
Doerga, M.E.3
Zelissen, P.M.4
Koppeschaar, H.P.5
-
81
-
-
0028890279
-
Persistent lipolytic effect of exogenous growth hormone during caloric restriction
-
Snyder, D. K., Underwood, L. E. & Clemmons, D. R. Persistent lipolytic effect of exogenous growth hormone during caloric restriction. Am. J. Med. 98, 129-134 (1995).
-
(1995)
Am. J. Med.
, vol.98
, pp. 129-134
-
-
Snyder, D.K.1
Underwood, L.E.2
Clemmons, D.R.3
-
82
-
-
1442352241
-
Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity
-
Albert, S. G. & Mooradian, A. D. Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity. J. Clin. Endocrinol. Metab. 89, 695-701 (2004).
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 695-701
-
-
Albert, S.G.1
Mooradian, A.D.2
-
83
-
-
0034235093
-
Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients
-
Richelsen, B. et al. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism 49, 906-911 (2000).
-
(2000)
Metabolism
, vol.49
, pp. 906-911
-
-
Richelsen, B.1
-
84
-
-
84870753316
-
Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: A randomized controlled trial
-
Makimura, H. et al. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial. J. Clin. Endocrinol. Metab. 97, 4769-4779 (2012).
-
(2012)
J. Clin. Endocrinol. Metab.
, vol.97
, pp. 4769-4779
-
-
Makimura, H.1
-
85
-
-
34249801228
-
Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: A factorial clinical trial
-
Attallah, H., Friedlander, A. L., Nino-Murcia, M. & Hoffman, A. R. Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial. PLoS Clin. Trials 2, e21 (2007).
-
(2007)
PLoS Clin. Trials
, vol.2
-
-
Attallah, H.1
Friedlander, A.L.2
Nino-Murcia, M.3
Hoffman, A.R.4
-
86
-
-
0033304520
-
Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins but not lipoprotein(a)
-
Svensson, J. et al. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins but not lipoprotein(a). J. Clin. Endocrinol. Metab. 84, 2028-2033 (1999).
-
(1999)
J. Clin. Endocrinol. Metab.
, vol.84
, pp. 2028-2033
-
-
Svensson, J.1
-
87
-
-
84859415664
-
Effects of GH in women with abdominal adiposity: A 6-month randomized, double-blind, placebo-controlled trial
-
Bredella, M. A. et al. Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial. Eur. J. Endocrinol. 166, 601-611 (2012).
-
(2012)
Eur. J. Endocrinol.
, vol.166
, pp. 601-611
-
-
Bredella, M.A.1
-
88
-
-
58149387611
-
Effects of recombinant human growth hormone therapy in obesity in adults: A meta analysis
-
Mekala, K. C. & Tritos, N. A. Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis. J. Clin. Endocrinol. Metab. 94, 130-137 (2009).
-
(2009)
J. Clin. Endocrinol. Metab.
, vol.94
, pp. 130-137
-
-
Mekala, K.C.1
Tritos, N.A.2
-
89
-
-
1442290249
-
Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome
-
Herrmann, B. L. et al. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome. Horm. Metab. Res. 36, 54-61 (2004).
-
(2004)
Horm. Metab. Res.
, vol.36
, pp. 54-61
-
-
Herrmann, B.L.1
-
90
-
-
79961242170
-
Growth hormone (GH)-induced insulin resistance is rapidly reversible: An experimental study in GH-deficient adults
-
Krusenstjerna-Hafstrøm, T. et al. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. J. Clin. Endocrinol. Metab. 96, 2548-2557 (2011).
-
(2011)
J. Clin. Endocrinol. Metab.
, vol.96
, pp. 2548-2557
-
-
Krusenstjerna-Hafstrøm, T.1
-
91
-
-
15644364105
-
Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure
-
Svensson, J. et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J. Clin. Endocrinol. Metab. 83, 362-369 (1998).
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, pp. 362-369
-
-
Svensson, J.1
-
92
-
-
36849058739
-
Metabolic effects of a growth hormone-releasing factor in patients with HIV
-
Falutz, J. et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N. Engl. J. Med. 357, 2359-2370 (2007).
-
(2007)
N. Engl. J. Med.
, vol.357
, pp. 2359-2370
-
-
Falutz, J.1
-
93
-
-
62749144043
-
Age-related changes in body composition of bovine growth hormone transgenic mice
-
Palmer, A. J. et al. Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150, 1353-1360 (2009).
-
(2009)
Endocrinology
, vol.150
, pp. 1353-1360
-
-
Palmer, A.J.1
-
94
-
-
80855128727
-
Plasma proteomic profiles of bovine growth hormone transgenic mice as they age
-
Ding, J., Berryman, D. E. & Kopchick, J. J. Plasma proteomic profiles of bovine growth hormone transgenic mice as they age. Transgenic Res. 20, 1305-1320 (2011).
-
(2011)
Transgenic Res.
, vol.20
, pp. 1305-1320
-
-
Ding, J.1
Berryman, D.E.2
Kopchick, J.J.3
-
95
-
-
0023688545
-
Expression of insulin-like growth factor i in transgenic mice with elevated levels of growth hormone is correlated with growth
-
Mathews, L. S., Hammer, R. E., Brinster, R. L. & Palmiter, R. D. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 123, 433-437 (1988).
-
(1988)
Endocrinology
, vol.123
, pp. 433-437
-
-
Mathews, L.S.1
Hammer, R.E.2
Brinster, R.L.3
Palmiter, R.D.4
-
96
-
-
53249134458
-
Role of the GH/IGF-1 axis in lifespan and healthspan: Lessons from animal models
-
Berryman, D. E., Christiansen, J. S., Johannsson, G., Thorner, M. O. & Kopchick, J. J. Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm. IGF Res. 18, 455-471 (2008).
-
(2008)
Growth Horm. IGF Res.
, vol.18
, pp. 455-471
-
-
Berryman, D.E.1
Christiansen, J.S.2
Johannsson, G.3
Thorner, M.O.4
Kopchick, J.J.5
-
97
-
-
33646767090
-
Effect of growth hormone on susceptibility to diet-induced obesity
-
Berryman, D. E. et al. Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 147, 2801-2808 (2006).
-
(2006)
Endocrinology
, vol.147
, pp. 2801-2808
-
-
Berryman, D.E.1
-
98
-
-
0032802960
-
Transgenic models of growth hormone action
-
Kopchick, J. J., Bellush, L. L. & Coschigano, K. T. Transgenic models of growth hormone action. Annu. Rev. Nutr. 19, 437-461 (1999).
-
(1999)
Annu. Rev. Nutr.
, vol.19
, pp. 437-461
-
-
Kopchick, J.J.1
Bellush, L.L.2
Coschigano, K.T.3
-
99
-
-
3042815659
-
Comparing adiposity profiles in three mouse models with altered GH signaling
-
Berryman, D. E. et al. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm. IGF Res. 14, 309-318 (2004).
-
(2004)
Growth Horm. IGF Res.
, vol.14
, pp. 309-318
-
-
Berryman, D.E.1
-
100
-
-
19944426672
-
Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
-
Bohlooly, Y. M. et al. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. Diabetes 54, 51-62 (2005).
-
(2005)
Diabetes
, vol.54
, pp. 51-62
-
-
Bohlooly, Y.M.1
-
101
-
-
34250884797
-
Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice
-
Wang, Z., Masternak, M. M., Al-Regaiey, K. A. & Bartke, A. Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148, 2845-2853 (2007).
-
(2007)
Endocrinology
, vol.148
, pp. 2845-2853
-
-
Wang, Z.1
Masternak, M.M.2
Al-Regaiey, K.A.3
Bartke, A.4
-
102
-
-
12344326642
-
Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet
-
Olsson, B. et al. Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology 146, 920-930 (2005).
-
(2005)
Endocrinology
, vol.146
, pp. 920-930
-
-
Olsson, B.1
-
103
-
-
0242490056
-
Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice
-
Bartke, A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78, 210-216 (2003).
-
(2003)
Neuroendocrinology
, vol.78
, pp. 210-216
-
-
Bartke, A.1
-
104
-
-
82355165082
-
Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner
-
Gahete, M. D. et al. Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner. Endocrinology 152, 4825-4837 (2011).
-
(2011)
Endocrinology
, vol.152
, pp. 4825-4837
-
-
Gahete, M.D.1
-
105
-
-
79958243025
-
Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse
-
List, E. O. et al. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr. Rev. 32, 356-386 (2011).
-
(2011)
Endocr. Rev.
, vol.32
, pp. 356-386
-
-
List, E.O.1
-
106
-
-
12644257576
-
A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
-
Zhou, Y. et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl Acad. Sci. USA 94, 13215-13220 (1997).
-
(1997)
Proc. Natl Acad. Sci. USA
, vol.94
, pp. 13215-13220
-
-
Zhou, Y.1
-
107
-
-
43449083772
-
Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: Novel findings
-
Bartke, A. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings. Aging Cell 7, 285-290 (2008).
-
(2008)
Aging Cell
, vol.7
, pp. 285-290
-
-
Bartke, A.1
-
108
-
-
0041419437
-
Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor i levels and increased life span
-
Coschigano, K. T. et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144, 3799-3810 (2003).
-
(2003)
Endocrinology
, vol.144
, pp. 3799-3810
-
-
Coschigano, K.T.1
-
109
-
-
74049103564
-
Two-year body composition analyses of long-lived GHR null mice
-
Berryman, D. E. et al. Two-year body composition analyses of long-lived GHR null mice. J. Gerontol. A. Biol. Sci. Med. Sci. 65, 31-40 (2010).
-
(2010)
J. Gerontol. A. Biol. Sci. Med. Sci.
, vol.65
, pp. 31-40
-
-
Berryman, D.E.1
-
110
-
-
33644855561
-
Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice
-
Egecioglu, E. et al. Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am. J. Physiol. Endocrinol. Metab. 290, E317-E325 (2006).
-
(2006)
Am. J. Physiol. Endocrinol. Metab.
, vol.290
-
-
Egecioglu, E.1
-
111
-
-
33751044208
-
Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: Site-specific effects upon proliferation, differentiation and hormone sensitivity
-
Flint, D. J., Binart, N., Boumard, S., Kopchick, J. J. & Kelly, P. Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J. Endocrinol. 191, 101-111 (2006).
-
(2006)
J. Endocrinol.
, vol.191
, pp. 101-111
-
-
Flint, D.J.1
Binart, N.2
Boumard, S.3
Kopchick, J.J.4
Kelly, P.5
-
112
-
-
33745219182
-
Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics
-
Bonkowski, M. S. et al. Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 562-567 (2006).
-
(2006)
J. Gerontol. A. Biol. Sci. Med. Sci.
, vol.61
, pp. 562-567
-
-
Bonkowski, M.S.1
-
113
-
-
0037315784
-
Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice
-
Li, Y., Knapp, J. R. & Kopchick, J. J. Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice. Exp. Biol. Med. (Maywood) 228, 207-215 (2003).
-
(2003)
Exp. Biol. Med. (Maywood)
, vol.228
, pp. 207-215
-
-
Li, Y.1
Knapp, J.R.2
Kopchick, J.J.3
-
114
-
-
4143085927
-
Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice
-
Liu, J. L. et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 287, E405-E413 (2004).
-
(2004)
Am. J. Physiol. Endocrinol. Metab.
, vol.287
-
-
Liu, J.L.1
-
115
-
-
84855832253
-
Metabolic effects of intra-abdominal fat in GHRKO mice
-
Masternak, M. M. et al. Metabolic effects of intra-abdominal fat in GHRKO mice. Aging Cell 11, 73-81 (2012).
-
(2012)
Aging Cell
, vol.11
, pp. 73-81
-
-
Masternak, M.M.1
-
116
-
-
84875067801
-
Adiponectin in mice with altered growth hormone action: Links to insulin sensitivity and longevity?
-
Lubbers, E. R. et al. Adiponectin in mice with altered growth hormone action: links to insulin sensitivity and longevity? J. Endocrinol. 216, 363-374 (2013).
-
(2013)
J. Endocrinol
, vol.216
, pp. 363-374
-
-
Lubbers, E.R.1
-
117
-
-
27744445115
-
Caloric restriction results in decreased expression of peroxisome proliferator-activated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice
-
Masternak, M. M. et al. Caloric restriction results in decreased expression of peroxisome proliferator-activated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice. J. Gerontol. A. Biol. Sci. Med. Sci. 60, 1238-1245 (2005).
-
(2005)
J. Gerontol. A. Biol. Sci. Med. Sci.
, vol.60
, pp. 1238-1245
-
-
Masternak, M.M.1
-
118
-
-
74649083738
-
Daily energy balance in growth hormone receptor/binding protein (GHR -/-) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency
-
Longo, K. A. et al. Daily energy balance in growth hormone receptor/binding protein (GHR -/-) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency. Growth Horm. IGF Res. 20, 73-79 (2010).
-
(2010)
Growth Horm. IGF Res.
, vol.20
, pp. 73-79
-
-
Longo, K.A.1
-
119
-
-
84874507612
-
The role of GH in adipose tissue: Lessons from adipose-specific GH receptor gene-disrupted mice
-
List, E. O. et al. The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol. Endocrinol. 27, 524-535 (2013).
-
(2013)
Mol. Endocrinol.
, vol.27
, pp. 524-535
-
-
List, E.O.1
-
120
-
-
0024229140
-
Diet-induced type II diabetes in C57BL/6J mice
-
Surwit, R. S., Kuhn, C. M., Cochrane, C., McCubbin, J. A. & Feinglos, M. N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37, 1163-1167 (1988).
-
(1988)
Diabetes
, vol.37
, pp. 1163-1167
-
-
Surwit, R.S.1
Kuhn, C.M.2
Cochrane, C.3
McCubbin, J.A.4
Feinglos, M.N.5
-
121
-
-
0029065480
-
Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice
-
Surwit, R. S. et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44, 645-651 (1995).
-
(1995)
Metabolism
, vol.44
, pp. 645-651
-
-
Surwit, R.S.1
-
122
-
-
84865408230
-
The decline in pulsatile GH secretion throughout early adulthood in mice is exacerbated by dietary-induced weight gain
-
Huang, L. et al. The decline in pulsatile GH secretion throughout early adulthood in mice is exacerbated by dietary-induced weight gain. Endocrinology 153, 4380-4388 (2012).
-
(2012)
Endocrinology
, vol.153
, pp. 4380-4388
-
-
Huang, L.1
-
123
-
-
67650649523
-
Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes
-
List, E. O. et al. Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes. Diabetologia 52, 1647-1655 (2009).
-
(2009)
Diabetologia
, vol.52
, pp. 1647-1655
-
-
List, E.O.1
-
124
-
-
0001651621
-
Breeding of mouse strains for diabetes mellitus
-
Nishimura M. Breeding of mouse strains for diabetes mellitus. Exp. Anim. 18, 147-157 (1969).
-
(1969)
Exp. Anim.
, vol.18
, pp. 147-157
-
-
Nishimura, M.1
-
125
-
-
7644237617
-
Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice
-
Hioki, C. et al. Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice. Horm. Metab. Res. 36, 607-613 (2004).
-
(2004)
Horm. Metab. Res.
, vol.36
, pp. 607-613
-
-
Hioki, C.1
-
126
-
-
13044294029
-
Liver-derived insulin-like growth factor i (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
-
Sjögren, K. et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl Acad. Sci. USA 96, 7088-7092 (1999).
-
(1999)
Proc. Natl Acad. Sci. USA
, vol.96
, pp. 7088-7092
-
-
Sjögren, K.1
-
127
-
-
0023616485
-
Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary
-
Casanueva, F. F. et al. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J. Clin. Endocrinol. Metab. 65, 634-642 (1987).
-
(1987)
J. Clin. Endocrinol. Metab.
, vol.65
, pp. 634-642
-
-
Casanueva, F.F.1
-
128
-
-
84555183257
-
The intricate role of growth hormone in metabolism
-
Vijayakumar, A., Yakar, S. & Leroith, D. The intricate role of growth hormone in metabolism. Front. Endocrinol. (Lausanne) 2, 32 (2011).
-
(2011)
Front. Endocrinol. (Lausanne)
, vol.2
, pp. 32
-
-
Vijayakumar, A.1
Yakar, S.2
Leroith, D.3
-
129
-
-
0035491321
-
Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure
-
Nielsen, S., Møller, N., Christiansen, J. S. & Jørgensen, J. O. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50, 2301-2308 (2001).
-
(2001)
Diabetes
, vol.50
, pp. 2301-2308
-
-
Nielsen, S.1
Møller, N.2
Christiansen, J.S.3
Jørgensen, J.O.4
-
130
-
-
78650850032
-
GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism
-
Barclay, J. L. et al. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology 152, 181-192 (2011).
-
(2011)
Endocrinology
, vol.152
, pp. 181-192
-
-
Barclay, J.L.1
-
131
-
-
84862727190
-
Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy
-
Nishizawa, H. et al. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. Eur. J. Endocrinol. 167, 67-74 (2012).
-
(2012)
Eur. J. Endocrinol.
, vol.167
, pp. 67-74
-
-
Nishizawa, H.1
-
132
-
-
0034489210
-
Insulin regulation of human hepatic growth hormone receptors: Divergent effects on biosynthesis and surface translocation
-
Leung, K. C., Doyle, N., Ballesteros, M., Waters, M. J. & Ho, K. K. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J. Clin. Endocrinol. Metab. 85, 4712-4720 (2000).
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 4712-4720
-
-
Leung, K.C.1
Doyle, N.2
Ballesteros, M.3
Waters, M.J.4
Ho, K.K.5
-
133
-
-
78651094465
-
Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat
-
Schulz, T. J. et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc. Natl Acad. Sci. USA 108, 143-148 (2011).
-
(2011)
Proc. Natl Acad. Sci. USA
, vol.108
, pp. 143-148
-
-
Schulz, T.J.1
-
134
-
-
78049295202
-
Fibrosis in human adipose tissue: Composition, distribution, and link with lipid metabolism and fat mass loss
-
Divoux, A. et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 59, 2817-2825 (2010).
-
(2010)
Diabetes
, vol.59
, pp. 2817-2825
-
-
Divoux, A.1
-
135
-
-
34547186534
-
CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice
-
Kelder, B. et al. CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice. Growth Horm. IGF Res. 17, 346-351 (2007).
-
(2007)
Growth Horm. IGF Res.
, vol.17
, pp. 346-351
-
-
Kelder, B.1
-
136
-
-
0025766522
-
Exogenous human growth hormone reduces body fat in obese women
-
Skaggs, S. R. & Crist, D. M. Exogenous human growth hormone reduces body fat in obese women. Horm. Res. 35, 19-24 (1991).
-
(1991)
Horm. Res.
, vol.35
, pp. 19-24
-
-
Skaggs, S.R.1
Crist, D.M.2
-
137
-
-
0029020117
-
Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects
-
Drent, M. L., Wever, L. D., Ader, H. J. & van der Veen, E. A. Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects. Eur. J. Endocrinol. 132, 565-572 (1995).
-
(1995)
Eur. J. Endocrinol.
, vol.132
, pp. 565-572
-
-
Drent, M.L.1
Wever, L.D.2
Ader, H.J.3
Van Der Veen, E.A.4
-
138
-
-
79251638798
-
Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes
-
Luque, R. M. et al. Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS ONE 6, e15767 (2011).
-
(2011)
PLoS ONE
, vol.6
-
-
Luque, R.M.1
-
139
-
-
0026377007
-
Glycine 119 of bovine growth hormone is critical for growth-promoting activity
-
Chen, W. Y., Wight, D. C., Mehta, B. V., Wagner, T. E. & Kopchick, J. J. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol. Endocrinol. 5, 1845-1852 (1991).
-
(1991)
Mol. Endocrinol.
, vol.5
, pp. 1845-1852
-
-
Chen, W.Y.1
Wight, D.C.2
Mehta, B.V.3
Wagner, T.E.4
Kopchick, J.J.5
-
140
-
-
0029608970
-
The Ames dwarf gene is required for Pit-1 gene activation
-
Andersen, B. et al. The Ames dwarf gene is required for Pit-1 gene activation. Dev. Biol. 172, 495-503 (1995).
-
(1995)
Dev. Biol.
, vol.172
, pp. 495-503
-
-
Andersen, B.1
-
141
-
-
33646012297
-
Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice
-
Wang, Z., Al-Regaiey, K. A., Masternak, M. M. & Bartke, A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 323-331 (2006).
-
(2006)
J. Gerontol. A. Biol. Sci. Med. Sci.
, vol.61
, pp. 323-331
-
-
Wang, Z.1
Al-Regaiey, K.A.2
Masternak, M.M.3
Bartke, A.4
-
142
-
-
0037322925
-
Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice
-
Heiman, M. L., Tinsley, F. C., Mattison, J. A., Hauck, S. & Bartke, A. Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice. Endocrine 20, 149-154 (2003).
-
(2003)
Endocrine
, vol.20
, pp. 149-154
-
-
Heiman, M.L.1
Tinsley, F.C.2
Mattison, J.A.3
Hauck, S.4
Bartke, A.5
-
143
-
-
0025014024
-
Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1
-
Li, S. et al. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347, 528-533 (1990).
-
(1990)
Nature
, vol.347
, pp. 528-533
-
-
Li, S.1
-
144
-
-
0035811073
-
Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production
-
Flurkey, K., Papaconstantinou, J., Miller, R. A. & Harrison, D. E. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl Acad. Sci. USA 98, 6736-6741 (2001).
-
(2001)
Proc. Natl Acad. Sci. USA
, vol.98
, pp. 6736-6741
-
-
Flurkey, K.1
Papaconstantinou, J.2
Miller, R.A.3
Harrison, D.E.4
-
145
-
-
0027455584
-
Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4
-
Donahue, L. R. & Beamer, W. G. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 136, 91-104 (1993).
-
(1993)
J. Endocrinol.
, vol.136
, pp. 91-104
-
-
Donahue, L.R.1
Beamer, W.G.2
-
146
-
-
0347664057
-
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
-
Holzenberger, M. et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182-187 (2003).
-
(2003)
Nature
, vol.421
, pp. 182-187
-
-
Holzenberger, M.1
|